DNAtrix

DNAtrix is a clinical-stage biotechnology company developing virus-driven cancer immunotherapies. DNAtrix’s platform leverages the unique properties of oncolytic viruses to develop a range of safe and effective treatments for difficult-to-treat cancers that have shown resistance to conventional therapies. DNAtrix continues to expand its pipeline by developing viruses with multiple potent immunomodulatory molecules designed to unleash a strong immune response against tumors.